Abstract
Purpose
Venous resection and reconstruction (VR) is a feasible surgical technique to achieve optimal outcomes in selected patients with pancreatic ductal adenocarcinoma (PDAC) who undergo open pancreaticoduodenectomy (OPD). However, data regarding patient outcomes in patients who undergo VR in robotic-assisted pancreaticoduodenectomy (RPD) are scarce.
Methods
All patients with a diagnosis of PDAC who underwent upfront open or robotic pancreatoduodenectomy with VR in a high-volume institution for pancreatic surgery between 2011 and 2019 were retrospectively reviewed. Perioperative and long-term outcomes were compared between the RPD and OPD cohorts.
Results
A total of 84 patients were included in the final analysis, 14 patients underwent RPD with VR and 70 who had OPD with VR. Reconstructed venous patency, postoperative 30-day morbidity, and 90-day mortality were comparable; however, lymph node resection rates were lower in the RPC cohort (p = 0.029). No difference was identified in 3-year survival rates between the two groups (34.0% versus 25.7% respectively, p = 0.667).
Conclusion
RPD with VR is a feasible approach for patients with PDAC and venous invasion. Further studies are needed to assess long-term outcomes compared to the open approach.
Similar content being viewed by others
Data availability
The authors are responsible for the data described in the manuscript and assure full availability of the study material.
References
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913–2921. https://doi.org/10.1158/0008-5472.CAN-14-0155
Kneuertz PJ, Pitt HA, Bilimoria KY, Smiley JP, Cohen ME, Ko CY, Pawlik TM (2012) Risk of morbidity and mortality following hepato-pancreato-biliary surgery. J Gastrointest Surg 16(9):1727–1735. https://doi.org/10.1007/s11605-012-1938-y
Kleespies A, Rentsch M, Seeliger H, Albertsmeier M, Jauch KW, Bruns CJ (2009) Blumgart anastomosis for pancreaticojejunostomy minimizes severe complications after pancreatic head resection. Br J Surg 96(7):741–750. https://doi.org/10.1002/bjs.6634
Zhang XM, Fan H, Kou JT, Zhang XX, Li P, Dai Y, He Q (2016) Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer. J Gastroenterol Hepatol 31(8):1498–1503. https://doi.org/10.1111/jgh.13299
Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362(17):1605–1617. https://doi.org/10.1056/NEJMra0901557
Kamisawa T, Wood LD, Itoi T, Takaori K (2016) Pancreatic cancer. Lancet 388(10039):73–85. https://doi.org/10.1016/S0140-6736(16)00141-0
Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD (2018) Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: patency rates and outcomes associated with thrombosis. J Surg Oncol 117(8):1648–1654. https://doi.org/10.1002/jso.25067
Landi F, Dopazo C, Sapisochin G, Beisani M, Blanco L, Caralt M, Balsells J, Charco R (2015) Long-term results of pancreaticoduodenectomy with superior mesenteric and portal vein resection for ductal adenocarcinoma in the head of the pancreas. Cir Esp 93(8):522–529. https://doi.org/10.1016/j.ciresp.2015.04.001
Ravikumar R, Sabin C, Abu Hilal M, Bramhall S, White S, Wigmore S, Imber CJ, Fusai G, Group UKVRiPCS (2014) Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study. J Am Coll Surg 218(3):401–411. https://doi.org/10.1016/j.jamcollsurg.2013.11.017
Ramacciato G, Mercantini P, Petrucciani N, Giaccaglia V, Nigri G, Ravaioli M, Cescon M, Cucchetti A, DelGaudio M (2009) Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? Ann Surg Oncol 16(4):817–825
Giovinazzo F, Turri G, Katz M, Heaton N, Ahmed I (2016) Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma. Br J Surg 103(3):179–191
Castleberry AW, White RR, De La Fuente SG, Clary BM, Blazer DG 3rd, McCann RL, Pappas TN, Tyler DS, Scarborough JE (2012) The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Ann Surg Oncol 19(13):4068–4077. https://doi.org/10.1245/s10434-012-2585-y
Burdío F, Grande L, Poves I (2019) What’s the next step in evaluating laparoscopic pancreaticoduodenectomy? Hepatobiliary Surg Nutr 8(5):555–556. https://doi.org/10.21037/hbsn.2019.07.13
Cai Y, Gao P, Li Y, Wang X, Peng B (2018) Laparoscopic pancreaticoduodenectomy with major venous resection and reconstruction: anterior superior mesenteric artery first approach. Surg Endosc 32(10):4209–4215
Croome KP, Farnell MB, Que FG, Reid-Lombardo KM, Truty MJ, Nagorney DM, Kendrick ML (2015) Pancreaticoduodenectomy with major vascular resection: a comparison of laparoscopic versus open approaches. J Gastrointest Surg 19(1):189–194. https://doi.org/10.1007/s11605-014-2644-8 (discussion 194)
Eguia E, Kuo PC, Sweigert PJ, Nelson MH, Aranha GV, Abood G, Godellas C, Baker MS (2019) The laparoscopic approach to pancreatoduodenectomy is cost neutral in very high-volume centers. Surgery. https://doi.org/10.1016/j.surg.2019.07.004
Palanivelu C, Senthilnathan P, Sabnis SC, Babu NS, Srivatsan Gurumurthy S, Anand Vijai N, Nalankilli VP, Praveen Raj P, Parthasarathy R, Rajapandian S (2017) Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours. Br J Surg 104(11):1443–1450. https://doi.org/10.1002/bjs.10662
de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P, Daams F, van Dam R, Dejong C, van Duyn E, Dijkgraaf M, van Eijck C, Festen S, Gerhards M, Groot Koerkamp B, de Hingh I, Kazemier G, Klaase J, de Kleine R, van Laarhoven C, Luyer M, Patijn G, Steenvoorde P, Suker M, Abu Hilal M, Busch O, Besselink M (2019) Minimally invasive versus open distal pancreatectomy (LEOPARD): a multicenter patient-blinded randomized controlled trial. Ann Surg 269(1):2–9
Fan CJ, Hirose K, Walsh CM, Quartuccio M, Desai NM, Singh VK, Kalyani RR, Warren DS, Sun Z, Hanna MN, Makary MA (2017) Laparoscopic total pancreatectomy with islet autotransplantation and intraoperative islet separation as a treatment for patients with chronic pancreatitis. JAMA Surg 152(6):550–556. https://doi.org/10.1001/jamasurg.2016.5707
Giulianotti P, Addeo P, Buchs N, Ayloo S, Bianco F (2011) Robotic extended pancreatectomy with vascular resection for locally advanced pancreatic tumors. Pancreas 40(8):1264–1270
Kauffmann E, Napoli N, Menonna F, Vistoli F, Amorese G, Campani D, Pollina LE, Funel N, Cappelli C, Caramella D, Boggi U (2016) Robotic pancreatoduodenectomy with vascular resection. Langenbecks Arch Surg 401(8):1111–1122
Allan B, Novak S, Hogg M, Zeh H (2018) Robotic vascular resections during Whipple procedure. J Vis Surg 4:13
Shyr BU, Chen SC, Shyr YM, Wang SE (2020) Surgical, survival, and oncological outcomes after vascular resection in robotic and open pancreaticoduodenectomy. Surgical endoscopy 34(1):377–383
Beane J, Zenati M, Hamad A, Hogg M, Zeh H, Zureikat A (2019) Robotic pancreatoduodenectomy with vascular resection: outcomes and learning curve. Surgery 166(1):8–14
Liu R, Wakabayashi G, Palanivelu C, Tsung A, Yang K, Goh BKP, Chong CC, Kang CM, Peng C, Kakiashvili E, Han HS, Kim HJ, He J, Lee JH, Takaori K, Marino MV, Wang SN, Guo T, Hackert T, Huang TS, Anusak Y, Fong Y, Nagakawa Y, Shyr YM, Wu YM, Zhao Y (2019) International consensus statement on robotic pancreatic surgery. Hepatobiliary Surg Nutr 8(4):345–360. https://doi.org/10.21037/hbsn.2019.07.08
Clavien PA, Barkun J, De Oliveira ML, Vauthey JN, Dindo D, Schulick RD, De Santibañes E, Pekolj J, Slankamenac K, Bassi C (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196
Chen S, Chen J, Zhan Q, Deng X, Shen B, Peng C, Li H (2015) Robot-assisted laparoscopic versus open pancreaticoduodenectomy: a prospective, matched, mid-term follow-up study. Surg Endosc 29(12):3698–3711
Chen S, Zhan Q, Chen J-z, Jin J-b, Deng X-x, Chen H, Shen B-y, Peng C-h, Li H-w (2015) Robotic approach improves spleen-preserving rate and shortens postoperative hospital stay of laparoscopic distal pancreatectomy: a matched cohort study. Surg Endosc 29(12):3507–3518
Chen S, Zhan Q, Jin J-b, Wu Z-c, Shi Y, Cheng D-f, Chen H, Deng X-x, Shen B-y, Peng C-h (2017) Robot-assisted laparoscopic versus open middle pancreatectomy: short-term results of a randomized controlled trial. Surg Endosc 31(2):962–971
Jin J, Qin K, Li H, Wu Z, Zhan Q, Deng X, Chen H, Shen B, Peng C, Li H (2016) Robotic enucleation for benign or borderline tumours of the pancreas: a retrospective analysis and comparison from a high-volume centre in Asia. World J Surg 40(12):3009–3020
Ironside N, Barreto S, Loveday B, Shrikhande S, Windsor JA, Pandanaboyana S (2018) Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival. Br J Surg 105(6):628–636
Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, Asbun HJ, Bassi C, Buchler M, Charnley RM, Conlon K, Cruz LF, Dervenis C, Fingerhutt A, Friess H, Gouma DJ, Hartwig W, Lillemoe KD, Montorsi M, Neoptolemos JP, Shrikhande SV, Takaori K, Traverso W, Vashist YK, Vollmer C, Yeo CJ, Izbicki JR, International Study Group of Pancreatic Surgery (ISGPS) (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155(6):977–988. https://doi.org/10.1016/j.surg.2014.02.001
Shyr BU, Chen SC, Shyr YM, Wang SE (2018) Learning curves for robotic pancreatic surgery-from distal pancreatectomy to pancreaticoduodenectomy. Medicine (Baltimore) 97(45):e13000. https://doi.org/10.1097/MD.0000000000013000
Worni M, Castleberry A, Clary B, Gloor B, Carvalho E, Jacobs D, Pietrobon R, Scarborough JE, White RR (2013) Concomitant vascular reconstruction during pancreatectomy for malignant disease: a propensity score-adjusted, population-based trend analysis involving 10,206 patients. JAMA Surg 148(4):331–338
Podda M, Thompson J, Kulli CTG, Tait IS (2017) Vascular resection in pancreaticoduodenectomy for periampullary cancers. A 10 year retrospective cohort study. Int J Surg 39:37–44. https://doi.org/10.1016/j.ijsu.2017.01.042
Kendrick ML, Sclabas GM (2011) Major venous resection during total laparoscopic pancreaticoduodenectomy. HPB (Oxford) 13(7):454–458
Capussotti L, Massucco P, Ribero D, Vigano L, Muratore A, Calgaro M (2003) Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 138(12):1316–1322. https://doi.org/10.1001/archsurg.138.12.1316
Kaneoka Y, Yamaguchi A, Isogai M (2009) Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Surgery 145(4):417–425. https://doi.org/10.1016/j.surg.2008.12.009
Riediger H, Makowiec F, Fischer E, Adam U, Hopt UT (2006) Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg 10(8):1106–1115. https://doi.org/10.1016/j.gassur.2006.04.002
Ouaissi M, Hubert C, Verhelst R, Astarci P, Sempoux C, Jouret-Mourin A, Loundou A, Gigot JF, Multidisciplinary HPBGoCoC (2010) Vascular reconstruction during pancreatoduodenectomy for ductal adenocarcinoma of the pancreas improves resectability but does not achieve cure. World J Surg 34(11):2648–2661. https://doi.org/10.1007/s00268-010-0699-6
Shi Y, Wang W, Qiu W, Zhao S, Wang J, Weng Y, Huo Z, Jin J, Wang Y, Deng X, Shen B, Peng C (2021) Learning curve from 450 cases of Robot-Assisted Pancreaticoduocectomy in a High-Volume Pancreatic Center: Optimization of operative procedure and a retrospective study. Annals of surgery 274(6):e1277–e1283
Jang JY, Han Y, Lee H, Kim SW, Kwon W, Lee KH, Oh DY, Chie EK, Lee JM, Heo JS, Park JO, Lim DH, Kim SH, Park SJ, Lee WJ, Koh YH, Park JS, Yoon DS, Lee IJ, Choi SH (2018) Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2/3 Trial. Ann Surg 268(2):215–222. https://doi.org/10.1097/SLA.0000000000002705
de Geus S, Kasumova G, Sachs T, Ng S, Kent T, Moser A, Vahrmeijer AL, Callery MP, Tseng JF (2018) Neoadjuvant therapy affects margins and margins affect all: perioperative and survival outcomes in resected pancreatic adenocarcinoma. HPB (Oxford) 20(6):573–581
Yang Y (2020) Current status and future prospect of surgical treatment for pancreatic cancer. Hepatobiliary Surg Nutr 9(1):89–91
Acknowledgements
The authors would like to thank all the participating patients and their families as well as the investigators, research nurses, study coordinators, and operation staff.
Funding
This study is sponsored by the Guangci Outstanding Youth Training Program (GCQN-2017-B06) and the Interdisciplinary Program of Shanghai Jiao Tong University (YG2019QNB26).
Author information
Authors and Affiliations
Contributions
Jiabin Jin MD, Shih-min Yin, and Yuanchi Weng conceived and designed the study. Mengmin Chen, Yusheng Shi, and Xiayang Ying made substantial contribution to data collection and analysis; Jiabin Jin MD, Shih-min Yin, Georgios Gemenetzis, and Yuanchi Weng participated in drafting the article; Georgios Gemenetzis, Xiaxing Deng, Chenghong Peng, and Baiyong Shen revised the manuscript critically for important intellectual contents. Jiabin Jin, Shih-min Yin, and Yuanchi Weng contributed equally to this work and should be considered co-first authors. Xiaxing Deng, Chenghong Peng, and Baiyong Shen also contributed equally and should be considered co-corresponding authors.
Corresponding authors
Ethics declarations
Research involving human participants and/or animals
The study was approved by the Ruijin Clinical Trial Ethics Committee, under authorization 2017–180, and was conducted at Shanghai JiaoTong University School of Medicine.
Informed consent
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Headings
1. Robotic pancreaticoduodenectomy with vascular resection is a feasible for patients with pancreatic cancer.
2. Robotic pancreaticoduodenectomy with vascular resection had similar oncological and survival outcome compared to an open method.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jin, J., Yin, Sm., Weng, Y. et al. Robotic versus open pancreaticoduodenectomy with vascular resection for pancreatic ductal adenocarcinoma: surgical and oncological outcomes from pilot experience. Langenbecks Arch Surg 407, 1489–1497 (2022). https://doi.org/10.1007/s00423-021-02364-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-021-02364-w